IP Library Granted Patent US 7,888,497
Granted Patent B2
US 7,888,497 · App. 10/709,572 · Granted Feb 15, 2011

Bioinformatically detectable group of novel regulatory oligonucleotides and uses thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,888,497
App. No.
10/709,572
Granted
Feb 15, 2011
Kind
B2
Abstract

The present invention relates to a first group of novel oligonucleotides, here identified as “Genomic Address Messenger” or “GAM” oligonucleotide, and a second group of novel operon-like polynucleotides, here identified as “Genomic Record” or “GR” polynucleotide. GAM oligonucleotides selectively inhibit translation of known “target” genes, many of which are known to be involved in various diseases. Nucleic acid molecules are provided respectively encoding 122,764 GAM oligonucleotides and their respective precursors, and 18602 GR polynucleotides, as are vectors and probes both comprising the nucleic acid molecules, and methods and systems for detecting GAM oligonucleotides and GR polynucleotides and specific functions and utilities thereof, for detecting expression of GAM oligonucleotides and GR polynucleotides, and for selectively enhancing and selectively inhibiting translation of the respective target genes thereof.

Claims (12)

1. An isolated nucleic acid consisting of a sequence selected from the group consisting of:

(a) SEQ ID NO:159;

(b) an RNA encoded by (a), wherein the RNA is identical in length to (a); and

(c) the complement of any one of (a) or (b), wherein the complement is identical in length to the nucleic acid of (a) or (b).

2. A vector comprising a human insert, wherein the human insert consists of the sequence of the nucleic acid of claim 1 , and wherein the vector comprises no other insert but the nucleic acid of claim 1 .

3. An oligonucleotide probe of 16-120 nucleotides in length, wherein the probe comprises the nucleic acid of claim 1 .

4. An isolated nucleic acid consisting of a sequence selected from the group consisting of:

(a) SEQ ID NO:6821380;

(b) an RNA encoded by (a), wherein the RNA is identical in length to (a); and

(c) the complement of any one of (a) or (b), wherein the complement is identical in length to the nucleic acid of (a) or (b).

5. A vector comprising a human insert, wherein the human insert consists of the sequence of the nucleic acid of claim 4 , and wherein the vector comprises no other insert but the nucleic acid of claim 4 .

6. An oligonucleotide probe of 16-120 nucleotides in length, wherein the probe comprises the nucleic acid of claim 4 .

Assignments (2)
SECURITY INTEREST Recorded Dec 15, 2017
From: ROSETTA GENOMICS INC.; ROSETTA GENOMICS LTD; MINUET DIAGNOSTICS, INC.; CYNOGEN INC.
To: GENOPTIX, INC.
Reel/Frame 044899/0237 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 14, 2004
From: BENTWICH, ITZHAK; AVNIEL, AMIR
To: ROSETTA GEMONICS LTD
Reel/Frame 014610/0418 →